Amicus Therapeutics, Inc. Financial Ratios — FOLD Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-48.71	-54.24	-50.19	-40.84	-23.63	-20.57	-34.14	-49.26	-43.46	-31.88	-27.96	-29.04	-20.18	-7.18	-3.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	285.07
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-698.76
Gross Margin (%)	100	100	100	100	- -	83.2	83.11	84.21	87.95	88.1	88.72	88.28	90.65	89.98	88.5
EBITDA Margin (%)	-230.02	-278.24	-16,659.5	-5,483.42	- -	-3,465.49	-561.3	-352.09	-162.41	-90.08	-63.4	-60.47	-16.43	8.07	6.61
Operating Margin (%)	-237.41	-287.5	-17,133.06	-5,609.8	- -	-3,530.88	-571.03	-356.71	-165.03	-93.47	-65.44	-62.09	-18.4	6.45	5.44
Incremental Operating Margin (%)	- -	- -	- -	- -	4,687.99	- -	- -	- -	- -	- -	- -	- -	- -	83.42	0.4
Pretax Margin (%)	-224.13	-282.6	-17,395.32	-5,722.14	- -	-4,110.15	-1,216.14	-382.58	-195.3	-105.12	-79.06	-73.52	-37.59	-5.44	0.03
Profit Margin (%)	-207.2	-264.98	-16,427.82	-5,631.21	- -	-4,034.73	-769.03	-382.48	-195.56	-106.12	-81.98	-71.85	-37.96	-10.62	-4.27
Net Income to Common Margin (%)	-207.2	-264.98	-16,427.82	-5,631.21	- -	-4,034.73	-769.03	-382.48	-195.56	-106.12	-81.98	-71.85	-37.96	-10.62	-4.27
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14,293.72
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	1	1	14	14	42	155	164	322	210	442	440	452	445	444	442
ST Debt	1	- -	- -	4	- -	- -	- -	- -	7	7	7	9	8	8	9
LT Debt	- -	- -	14	11	42	154	164	322	203	435	433	444	437	435	434
Total Debt/EBITDA	-0.02	-0.01	-0.24	-0.21	-0.33	-0.9	-0.79	-1	-0.71	-1.88	-2.27	-2.27	-6.78	10.41	10.54
Net Debt/EBITDA	0.5	0.65	0.48	0.14	0.22	0.19	-0.56	-0.75	-0.02	-0.96	-0.74	-1.22	-2.15	4.14	4.26
Total Debt/EBIT	-0.02	-0.01	-0.23	-0.21	-0.33	-0.88	-0.78	-0.99	-0.7	-1.81	-2.2	-2.21	-6.06	13.02	12.83
Net Debt/EBIT	0.48	0.63	0.47	0.14	0.22	0.19	-0.55	-0.74	-0.02	-0.93	-0.72	-1.19	-1.92	5.18	5.18
EBITDA to Interest Expense	-333.12	-575.57	-1,314.65	-45.23	-78.71	-31.83	-12.02	-14.34	-15.68	-10.48	-5.97	-5.36	-1.31	0.86	0.91
EBITDA-CapEx/Interest Expense	-342.72	-624.16	-1,329.76	-45.39	-81.77	-32.93	-12.29	-14.34	-15.68	-10.48	-5.97	-5.36	-1.31	0.86	0.91
EBIT to Interest Expense	-343.83	-594.73	-1,352.02	-46.27	-79.88	-32.43	-12.23	-14.53	-15.94	-10.87	-6.16	-5.51	-1.47	0.69	0.75
Interest Expense	- -	- -	- -	1	2	5	17	22	19	22	32	37	50	50	46
Common Equity/Total Assets	-386.41	-289.16	-296.2	-212.62	-63.66	-75.05	-169.35	-178.53	-207.72	-230.43	-253.34	-349.32	-344.67	-348.68	-291.01
Long-Term Debt/Equity (%)	- -	0.43	30.98	8.6	11.96	42.89	46.53	93.83	42.62	151.85	140.78	360.49	272.66	224.27	158.12
Long-Term Debt/Capital (%)	- -	-0.09	-3.9	-2.43	-7.75	-24.78	-18.29	-29.56	-13.05	-27.16	-23.35	-21.35	-19.53	-18.97	-18.68
Long-Term Debt/Total Assets (%)	- -	0.27	11.11	5.01	4.58	14.9	26.18	40.73	23.88	49.05	47.81	61.25	56.14	55.44	45.65
Total Debt/Equity (%)	3.53	1.01	31.63	11.75	11.96	42.97	46.61	93.83	44.13	154.25	143.19	367.44	277.86	228.63	161.3
Total Debt/Capital (%)	-0.39	-0.22	-3.98	-3.32	-7.75	-24.82	-18.33	-29.56	-13.51	-27.59	-23.75	-21.76	-19.9	-19.34	-19.05
Total Debt/Total Assets (%)	1.5	0.63	11.35	6.83	4.58	14.92	26.23	40.73	24.73	49.83	48.63	62.43	57.21	56.51	46.57
Net Debt to Equity	-83.21	-48.07	-63.75	-7.96	-8.02	-9.04	32.62	70.57	1.4	78.92	46.9	197.63	87.94	90.89	65.14
Net Debt/Capital (%)	8.37	9.46	7.17	2.13	4.6	4.02	-12.16	-20.71	-0.39	-12.81	-6.87	-10.92	-5.67	-7.03	-7.04
EBITDA	-49	-51	-60	-67	-124	-172	-207	-321	-296	-235	-194	-199	-66	43	42
EBITDA-CapEx	-51	-56	-61	-67	-129	-178	-212	-321	-296	-235	-194	-199	-66	43	42
Operating Income (Loss)	-51	-53	-62	-69	-126	-175	-211	-325	-301	-244	-200	-204	-73	34	34

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	2.89	10.72	7.84	7.51	2.91	2.98	5.12	5.85	3.51	3.73	3.31	2.11	1.71	1.68	1.23
Current Ratio	3.46	11.32	8.44	7.66	2.94	3.06	5.6	6.4	4.04	4.47	4.09	3.05	2.88	3.39	2.84
Quick Ratio	3.15	11.07	7.94	7.51	2.91	2.99	5.25	6.11	3.77	4.09	3.67	2.59	2.23	2.36	1.72
CFO/Avg Current Liab	-2.79	-2.37	-4.65	-3.37	-2.14	-1.63	-2.36	-3.84	-2.33	-1.81	-1.47	-1.17	-0.45	-0.21	0.17
Common Equity/Total Assets	-386.41	-289.16	-296.2	-212.62	-63.66	-75.05	-169.35	-178.53	-207.72	-230.43	-253.34	-349.32	-344.67	-348.68	-291.01
Long-Term Debt/Equity (%)	- -	0.43	30.98	8.6	11.96	42.89	46.53	93.83	42.62	151.85	140.78	360.49	272.66	224.27	158.12
Long-Term Debt/Capital (%)	- -	-0.09	-3.9	-2.43	-7.75	-24.78	-18.29	-29.56	-13.05	-27.16	-23.35	-21.35	-19.53	-18.97	-18.68
Long-Term Debt/Total Assets (%)	- -	0.27	11.11	5.01	4.58	14.9	26.18	40.73	23.88	49.05	47.81	61.25	56.14	55.44	45.65
Total Debt/Equity (%)	3.53	1.01	31.63	11.75	11.96	42.97	46.61	93.83	44.13	154.25	143.19	367.44	277.86	228.63	161.3
Total Debt/Capital (%)	-0.39	-0.22	-3.98	-3.32	-7.75	-24.82	-18.33	-29.56	-13.51	-27.59	-23.75	-21.76	-19.9	-19.34	-19.05
Total Debt/Total Assets (%)	1.5	0.63	11.35	6.83	4.58	14.92	26.23	40.73	24.73	49.83	48.63	62.43	57.21	56.51	46.57
CFO/Total Liabilities	-122.93	-82.57	-55.97	-58.86	-17.86	-22.19	-77.94	-67.1	-67	-38.87	-33.87	-27.71	-11.19	-5.73	4.91
CFO/CapEx	-34.8	-7.8	-65.89	-217.1	-20.79	-25.23	-47.21	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-4.93	-2.64	-6.02	0.3	-3.57	-3.35	0.49	-1.83	-0.72	1.67	-1.28	-3.53	-1.69	-1.95	-3.52

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	8.5	4.45	0.17	2.26	- -	7.6	6.86	5.81	6.6	6.51	6.14	5.54	5.19	5.6	5.86
Days Sales Outstanding	42.94	81.96	2,165.87	161.48	- -	48	53.21	62.86	55.33	56.11	59.49	65.89	70.3	65.2	62.27
Inventory Turnover	- -	- -	- -	- -	- -	0.49	1.55	2.21	1.96	1.85	1.49	1.52	0.89	0.59	0.42
Days Inventory Outstanding	- -	- -	- -	- -	- -	748.4	235.27	164.88	186.39	197.51	245.55	239.4	408.32	615.23	869.85
Accounts Payable Turnover	- -	- -	- -	- -	- -	0.29	0.72	2.51	1.95	1.89	2.16	1.93	4.8	7.98	8.8
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	1,261.99	509.32	145.36	187.22	193.61	168.71	189.31	76.12	45.72	41.47
Cash Conversion Cycle	- -	- -	- -	- -	- -	-465.59	-220.84	82.37	54.5	60	136.33	115.98	402.5	634.71	890.65
Inventory to Cash Days	- -	- -	- -	- -	- -	-700.4	-182.05	-102.02	-131.06	-141.4	-186.06	-173.51	-338.02	-550.03	-807.58
Inventories	- -	- -	- -	- -	- -	3	5	8	14	20	27	24	60	119	229
Raw Materials	- -	- -	- -	- -	- -	- -	2	1	7	6	12	10	30	88	131
Work In Process	- -	- -	- -	- -	- -	3	1	3	4	8	11	10	23	21	61
Finished Goods	- -	- -	- -	- -	- -	- -	1	4	4	6	4	4	7	10	36
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	119	122	121	619	1,066	668	2,207	1,780	2,342	5,977	3,135	3,529	4,188	2,867	- -
- Cash & Cash Equivalents	26	34	44	24	69	187	49	80	143	163	245	149	247	214	214
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	1	14	14	42	155	164	322	210	442	440	452	445	444	442
Enterprise Value	64	24	53	482	894	492	2,013	1,597	2,099	5,936	3,093	3,688	4,347	3,061	149
Total Capital	-269	-318	-363	-432	-537	-623	-897	-1,089	-1,556	-1,601	-1,853	-2,078	-2,236	-2,294	-2,322
Total Debt/Capital (%)	-0.39	-0.22	-3.98	-3.32	-7.75	-24.82	-18.33	-29.56	-13.51	-27.59	-23.75	-21.76	-19.9	-19.34	-19.05
Total Debt / EV	0.02	0.03	0.27	0.03	0.05	0.31	0.08	0.2	0.1	0.07	0.14	0.12	0.1	0.14	2.97
EV/Sales	3	1.29	145.99	393.83	- -	99.31	54.5	17.51	11.52	22.75	10.12	11.2	10.89	5.79	0.23
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	71.84	3.55
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	89.86	4.31
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.68	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.68	- -
Diluted Market Cap	119	122	121	619	1,066	668	2,207	1,780	2,342	5,977	3,135	3,529	4,188	2,867	- -
Diluted Enterprise Value	94	89	91	610	1,038	636	2,322	2,022	2,409	6,256	3,330	3,833	4,386	3,097	228
EV per Share	1.86	0.52	1.03	6.48	8.13	3.66	13.12	8.6	8.73	22.93	11.39	12.76	14.73	10.06	- -
TTM Sales	21	18	- -	1	- -	5	37	91	182	261	306	329	399	528	634
TTM EBITDA	-49	-51	-60	-67	-124	-172	-207	-321	-296	-235	-194	-199	-66	43	42
TTM Operating Income	-51	-53	-62	-69	-126	-175	-211	-325	-301	-244	-200	-204	-73	34	34
TTM Cash Flow to Firm	-49	-34	-46	-50	-99	-145	-203	-278	-232	-211	-169	-130	-18	63	-6,519
TTM Free Cash Flow to Firm	-48	-29	-45	-50	-94	-139	-198	-278	-232	-211	-169	-130	-18	63	-6,519

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-2.48	-4.15	-2.67	-12.04	-11.19	-4.63	-10.55	-5.93	-9.35	-25.62	-15.48	-21.19	-60.62	-84.6	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	89.86	4.31
Enterprise Value	64	24	53	482	894	492	2,013	1,597	2,099	5,936	3,093	3,688	4,347	3,061	149
Low Price	2.1	2.47	1.9	1.76	5.69	4.41	4.95	8.27	7.11	6.25	8.6	5.91	9.7	9.02	5.51
EV/Sales	3	1.29	145.99	393.83	- -	99.31	54.5	17.51	11.52	22.75	10.12	11.2	10.89	5.79	0.23
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	71.84	3.55
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-4.15	-4.92	-2.39	-4.61	-9.49	-4.66	-5.59	-7.36	-7.56	-13.3	-12.59	-12.24	-23.58	-60.04	- -
Price/Earnings High	-6.32	-6.81	-3.67	-9.49	-15.67	-6.6	-8.96	-9.38	-9.86	-23.74	-26.92	-15.84	-28.37	-78.83	- -
Price/Earnings Low	-1.63	-2.31	-1.63	-1.91	-4.73	-2.96	-2.67	-4.4	-4.8	-5.84	-9.32	-7.22	-18.89	-48.93	- -
Price/Book Value	-0.44	-0.38	-0.32	-1.39	-1.84	-0.86	-2.08	-1.26	-1.33	-2.93	-1.37	-1.4	-1.56	-1.05	- -
Price/Book Value Average	-0.68	-0.75	-0.38	-0.71	-2.17	-1.2	-1.49	-1.82	-1.53	-1.8	-1.37	-1.14	-1.33	-1.23	- -
Price/Book Value High	-1.04	-1.04	-0.58	-1.47	-3.58	-1.7	-2.4	-2.32	-1.99	-3.22	-2.94	-1.48	-1.6	-1.62	- -
Price/Book Value Low	-0.27	-0.35	-0.26	-0.29	-1.08	-0.76	-0.71	-1.09	-0.97	-0.79	-1.02	-0.68	-1.07	-1	- -
Price/Tangible Book Value	4.02	1.76	10.82	7.07	-3.17	-2.06	16.71	14.58	9.16	91.14	36.21	-36.11	-72.07	-136.86	- -
Price/Tangible Book Value Average	6.23	3.47	12.8	3.63	-3.73	-2.87	12.02	21.03	10.54	56.14	36.42	-29.62	-61.52	-160.8	- -
Price/Tangible Book Value High	9.49	4.8	19.66	7.47	-6.15	-4.07	19.28	26.81	13.75	100.22	77.88	-38.32	-74	-211.1	- -
Price/Tangible Book Value Low	2.45	1.63	8.75	1.5	-1.86	-1.83	5.75	12.58	6.69	24.67	26.96	-17.48	-49.27	-131.05	- -
Price/Sales	5.55	6.63	332.02	506.03	- -	134.73	59.76	19.51	12.85	22.91	10.26	10.72	10.49	5.43	- -
Price/Sales Average	8.6	13.03	392.77	259.45	- -	188.02	42.98	28.14	14.79	14.11	10.32	8.79	8.95	6.38	- -
Price/Sales High	13.1	18.04	603.28	534.61	- -	266.49	68.93	35.88	19.28	25.19	22.07	11.38	10.77	8.37	- -
Price/Sales Low	3.39	6.11	268.44	107.35	- -	119.55	20.56	16.84	9.38	6.2	7.64	5.19	7.17	5.2	- -
Price/Cash Flow	-2.41	-3.62	-2.63	-11.99	-10.65	-4.45	-10.33	-5.93	-9.35	-25.62	-15.48	-21.19	-60.62	-84.6	- -
Price/Cash Flow Average	-3.73	-7.11	-3.11	-6.15	-12.53	-6.21	-7.43	-8.56	-10.76	-15.78	-15.57	-17.38	-51.74	-99.4	- -
Price/Cash Flow High	-5.68	-9.84	-4.78	-12.66	-20.67	-8.8	-11.91	-10.91	-14.03	-28.17	-33.3	-22.49	-62.24	-130.5	- -
Price/Cash Flow Low	-1.47	-3.34	-2.13	-2.54	-6.25	-3.95	-3.55	-5.12	-6.83	-6.94	-11.53	-10.26	-41.44	-81.01	- -
Price/Free Cash Flow Average	-3.84	-8.15	-3.16	-6.17	-13.16	-6.46	-7.59	-8.56	-10.76	-15.78	-15.57	-17.38	-51.74	-99.4	- -
Price/Free Cash Flow High	-5.85	-11.29	-4.86	-12.72	-21.71	-9.16	-12.17	-10.91	-14.03	-28.17	-33.3	-22.49	-62.24	-130.5	- -
Price/Free Cash Flow Low	-1.51	-3.83	-2.16	-2.55	-6.56	-4.11	-3.63	-5.12	-6.83	-6.94	-11.53	-10.26	-41.44	-81.01	- -
EV/Sales Average	7.45	11.22	312.42	251.5	- -	181.51	46.1	30.8	15.16	15.18	10.96	9.72	9.45	6.81	0.36
EV/Sales High	11.95	16.23	522.93	526.67	- -	259.98	72.06	38.53	19.65	26.26	22.71	12.3	11.26	8.81	0.36
EV/Sales Low	2.24	4.31	188.09	99.4	- -	113.04	23.68	19.49	9.75	7.27	8.28	6.11	7.67	5.63	0.36
EV/EBITDA Average	-3.24	-4.03	-1.88	-4.59	-9.87	-5.24	-8.21	-8.75	-9.33	-16.85	-17.28	-16.07	-57.5	84.45	5.44
EV/EBITDA High	-5.19	-5.83	-3.14	-9.6	-16.44	-7.5	-12.84	-10.94	-12.1	-29.15	-35.81	-20.34	-68.55	109.19	5.44
EV/EBITDA Low	-0.97	-1.55	-1.13	-1.81	-4.81	-3.26	-4.22	-5.54	-6	-8.07	-13.06	-10.1	-46.65	69.83	5.44
EV/EBIT Average	-3.14	-3.9	-1.82	-4.48	-9.73	-5.14	-8.07	-8.63	-9.19	-16.24	-16.74	-15.65	-51.34	105.64	6.62
EV/EBIT High	-5.03	-5.65	-3.05	-9.39	-16.2	-7.36	-12.62	-10.8	-11.91	-28.1	-34.7	-19.81	-61.21	136.58	6.62
EV/EBIT Low	-0.94	-1.5	-1.1	-1.77	-4.74	-3.2	-4.15	-5.46	-5.91	-7.78	-12.65	-9.84	-41.65	87.35	6.62
Last Price	3.44	2.68	2.35	8.32	9.7	4.97	14.39	9.58	9.74	23.09	11.55	12.21	14.19	9.42	14.24
High Price	8.12	7.29	4.27	8.79	18.83	9.83	16.6	17.62	14.62	25.39	24.84	12.96	14.57	14.53	14.36
Enterprise Value Average	160	207	113	308	1,226	900	1,703	2,810	2,763	3,961	3,348	3,199	3,773	3,599	228
Enterprise Value High	256	299	190	645	2,042	1,289	2,661	3,516	3,581	6,851	6,937	4,049	4,499	4,653	228
Enterprise Value Low	48	79	68	122	598	560	875	1,778	1,777	1,896	2,529	2,012	3,061	2,975	228

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	35	50	62	96	125	143	167	189	255	262	279	281	294	299	311
Diluted Weighted Avg Shares	35	46	51	74	110	134	153	186	240	259	271	289	295	304	- -
Basic Weighted Avg Shares	35	46	51	74	110	134	153	186	240	259	271	289	295	304	- -
Revenue per Share	0.62	0.4	0.01	0.02	- -	0.04	0.24	0.49	0.76	1.01	1.13	1.14	1.35	1.74	- -
EBITDA per Share	-1.43	-1.12	-1.18	-0.9	-1.13	-1.28	-1.35	-1.73	-1.23	-0.91	-0.71	-0.69	-0.22	0.14	- -
Operating Income per Share	-1.47	-1.16	-1.21	-0.92	-1.15	-1.3	-1.38	-1.75	-1.25	-0.94	-0.74	-0.71	-0.25	0.11	- -
Basic EPS, GAAP	-1.28	-1.07	-1.16	-0.93	-1.2	-1.49	-1.85	-1.88	-1.48	-1.07	-0.92	-0.82	-0.51	-0.18	- -
Basic EPS from Cont Ops	-1.28	-1.07	-1.16	-0.93	-1.2	-1.49	-1.85	-1.88	-1.48	-1.07	-0.92	-0.82	-0.51	-0.18	- -
Diluted EPS, GAAP	-1.28	-1.07	-1.16	-0.93	-1.2	-1.49	-1.85	-1.88	-1.48	-1.07	-0.92	-0.82	-0.51	-0.18	- -
Diluted EPS from Cont Ops	-1.28	-1.07	-1.16	-0.93	-1.2	-1.49	-1.85	-1.88	-1.48	-1.07	-0.92	-0.82	-0.51	-0.18	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.43	-0.74	-0.89	-0.69	-0.91	-1.12	-1.39	-1.61	-1.04	-0.9	-0.75	-0.58	-0.23	-0.11	- -
Free Cash Flow per Basic Share	-1.47	-0.84	-0.91	-0.7	-0.95	-1.16	-1.42	-1.61	-1.04	-0.9	-0.75	-0.58	-0.23	-0.11	- -
Cash & Equivalents per Share	1.61	2.18	1.6	2.04	1.95	2.46	2.34	2.71	1.88	1.87	1.78	1.02	0.97	0.82	- -
Book Value per Share	-7.8	-6.99	-7.37	-6	-5.26	-5.79	-6.92	-7.59	-7.35	-7.89	-8.45	-8.75	-9.08	-8.99	- -
Tangible Book Value per Share	0.86	1.52	0.22	1.18	-3.06	-2.41	0.86	0.66	1.06	0.25	0.32	-0.34	-0.2	-0.07	- -

Amicus Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)